Kenneth W. Culver
Research Subjects
Research Interests
Kenneth W. Culver has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Alexander Khorlin
Novartis
1 shared publicationJilan Liu
1 shared publicationVivian Chen
1 shared publicationWang-Ting Hsieh
1 shared publicationYentram Huyen
1 shared publicationYuri Khripine
1 shared publication
Latest Publications
- 1 October 1999
- Published by Springer Nature in Nature Biotechnology
- Vol. 17 (10) , 989-993
Correction of chromosomal point mutations in human cells with bifunctional oligonucleotides
A sequence-specific genomic delivery system for the correction of chromosomal mutations was designed by incorporating two different binding domains into a single-stranded oligonucleotide. A repair domain (RD) contained the native sequence of the target region. A third strand-forming domain (TFD) was designed to form a triplex by Hoogsteen interactions. The design was based upon the premise that the RD will rapidly form a heteroduplex that is anchored synergistically by the TFD. Deoxyoligonucleotides were designed to form triplexes in the human adenosine deaminase (ADA) and p53 genes adjacent to known point mutations. Transfection of ADA-deficient human lymphocytes corrected the mutant sequence in 1–2% of cells. Neither the RD or TFD individually corrected the mutation. Transfection of p53 mutant human glioblastoma cells corrected the mutation and induced apoptosis in 7.5% of cells.
- 1 October 1999
- Published by Springer Nature in Nature Biotechnology
- Vol. 17 (10) , 989-993
Correction of chromosomal point mutations in human cells with bifunctional oligonucleotides
A sequence-specific genomic delivery system for the correction of chromosomal mutations was designed by incorporating two different binding domains into a single-stranded oligonucleotide. A repair domain (RD) contained the native sequence of the target region. A third strand-forming domain (TFD) was designed to form a triplex by Hoogsteen interactions. The design was based upon the premise that the RD will rapidly form a heteroduplex that is anchored synergistically by the TFD. Deoxyoligonucleotides were designed to form triplexes in the human adenosine deaminase (ADA) and p53 genes adjacent to known point mutations. Transfection of ADA-deficient human lymphocytes corrected the mutant sequence in 1–2% of cells. Neither the RD or TFD individually corrected the mutation. Transfection of p53 mutant human glioblastoma cells corrected the mutation and induced apoptosis in 7.5% of cells.